Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/11/2025 ,inter alia, to consider and approve Pursuant to Regulation 29(1) ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem has informed BSE that its Board of Directors meeting, originally scheduled for 14th November 2025, has been rescheduled to 19th November 2025 at 4:30 P.M. due to unavoidable circumstances. The meeting will be held at the company's registered office in Ahmedabad. The Board will, among other things, consider and approve the Unaudited Financial Results for the Half Year ended 30th September 2025, along with the Limited Review Report. The intimation is filed under Regulation 29(1) of SEBI LODR Regulations, 2015.
This is a procedural update with no direct impact on shareholders or the stock price. Investors should watch for the H1 FY26 (half-year ended September 2025) results, which are now expected to be announced on or after 19th November 2025.